Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Lung support machine under the microscope: new study examines Real-World use in ICUs

NCT ID NCT07161271

First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 28 times

Summary

This study looks back at medical records of about 60 ICU patients who received a treatment called low-flow ECCO2R, which helps remove carbon dioxide from the blood when the lungs are failing. Researchers want to describe how the therapy is used in practice and what outcomes patients have, including survival and side effects. The goal is to improve the safety and quality of this breathing support for future patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Queen Mary Hospital (QMH)

    RECRUITING

    Hong Kong, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.